- The trend backdrop is active with a 13-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Volume is elevated versus the 13-week average, confirming attention.
SDZ
VIE
Week ended 07 Aug 2026
Weekly Investor Report
Sandoz Group AG · Healthcare · Drug Manufacturers - Specialty & Generic
Latest close
77.28 EUR
8.1%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 9.2% above the Trend Line and sits at 94.0% of its 52-week range. The latest completed week returned 8.1%, after a 5.1% four-week move. The latest news-sentiment score is 50/100. Near-term considerations: price is close to its 52-week high.
Setup score
56
out of 100
Latest Close
77.28 EUR
7 Aug 2026
1W Return
8.1%
latest completed week
4W Return
5.1%
short-term follow-through
12W Return
6.0%
quarterly tape
Trend Breadth
31.0%
13 of 42 weeks active
Volume Ratio
1.6x
vs 13-week average
- Activity pressure is negative, which weakens the current setup.
- 2 reversal markers appear in the recent smart-money tape.
- Price is close to its 52-week high; watch for continuation or exhaustion.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
8.1%
Latest completed week; four-week move 5.1%.
Indicator stack
62/16
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
50/100
7 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 9.2% above the Trend Line and sits at 94.0% of its 52-week range. The latest completed week returned 8.1%, after a 5.1% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.6x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.8612-week average 0.77
12-week confirmation
Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure3/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.86Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers
No recent accumulation markers. 2 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 5.1% over four weeks, 6.0% over 12 weeks, and - over one year. The current trend has remained active for 13 consecutive weeks.
Performance by holding period
Active trend streak13 weeks
Active weeks in one year13
Trend breadth31.0%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.33Latest activity-pressure read.
Pressure change-355.3%Four-week change in activity pressure.
Leadership-Latest relative-leadership reading.
RS change-Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 7 relevant articles.
0 positive · 7 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-2.0%Distance below the 52-week high.
13-week volatility4.1%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher14 of 2612 weeks finished lower.
Best week+8.1%Week of 7 Aug.
Worst week-7.4%Week of 6 Mar.
Latest week+8.1%Week of 7 Aug.
Shape of recent returns
Strong gains7
Modest gains7
Flat weeks0
Modest losses10
Sharp losses2
Recent vol4.1%13-week weekly-return volatility.
Base vol3.8%52-week weekly-return volatility.
Up/down split23/18Count of positive and negative weeks in the 52-week window.
Average skew3.7% / -2.5%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorAT Healthcare
4-week rank34 / 100
Group average2.6%
Trend breadth47.0%
Trend47.0%active weekly trend signals
MD73.0%positive activity pressure
RS10.0%positive relative leadership
Four-week leaders
IndustryAT Drug Manufacturers - Specialty & Generic
4-week rank3 / 16
Group average-0.9%
Trend breadth50.0%
Trend50.0%active weekly trend signals
MD12.5%positive activity pressure
RS12.5%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape54/100
Trend, activity pressure, participation, and risk combine to a 54/100 tape read.
Indicator analysis51/100Latest 12-week confirmation: trend 12/12, activity pressure 3/12, relative leadership 0/12.
Activity pressure 0.86; 2 reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 7 relevant articles.
Sandoz Group (SWX:SDZ) Could Be 38% Below Fair Value On Mixed Half Year Earnings Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 77.28 EUR | 8.1% | 70.76 EUR | 67.56 EUR | -0.33 | - | 127 | On |
| 31 Jul 2026 | 71.52 EUR | 4.0% | 70.32 EUR | 67.32 EUR | -0.33 | - | 0 | On |
| 24 Jul 2026 | 68.74 EUR | -2.8% | 69.98 EUR | 67.21 EUR | -0.18 | - | 0 | On |
| 17 Jul 2026 | 70.70 EUR | -3.8% | 69.77 EUR | 67.17 EUR | 0.01 | - | 130 | On |
| 10 Jul 2026 | 73.52 EUR | -6.7% | 69.44 EUR | 67.08 EUR | 0.13 | - | 127 | On |
| 3 Jul 2026 | 78.76 EUR | 1.0% | 69.04 EUR | 66.91 EUR | 0.09 | - | 0 | On |
| 26 Jun 2026 | 77.98 EUR | 6.4% | 68.46 EUR | 66.58 EUR | -0.11 | - | 80 | On |
| 19 Jun 2026 | 73.32 EUR | 0.8% | 67.86 EUR | 66.25 EUR | -0.21 | - | 90 | On |
| 12 Jun 2026 | 72.76 EUR | 3.7% | 67.35 EUR | 66.05 EUR | -0.31 | - | 0 | On |
| 5 Jun 2026 | 70.16 EUR | -2.5% | 66.89 EUR | 65.84 EUR | -0.32 | - | 314 | On |
| 29 May 2026 | 71.96 EUR | 1.8% | 66.41 EUR | 65.71 EUR | -0.23 | - | 152 | On |
| 22 May 2026 | 70.72 EUR | -3.0% | 65.92 EUR | 65.51 EUR | -0.28 | - | 0 | On |
| 15 May 2026 | 72.88 EUR | -1.1% | 65.33 EUR | 65.33 EUR | -0.29 | - | 0 | On |
| 8 May 2026 | 73.66 EUR | 7.8% | - | 65.07 EUR | -0.25 | - | 304 | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.